Stimulation with a Monoclonal Antibody (mAb4E4) of Scavenger Receptor-mediated Uptake of Chemically Modified Low Density Lipoproteins by THP-1-derived Macrophages Enhances Foam Cell Generation

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1994 Jan 1

PMID 8282826

Citations 3

Authors

P Holvoet

G Perez

H Bernar

E Brouwers

B Vanloo

M Rosseneu

D Collen

Affiliations

Soon will be listed here.

Abstract

mAb4E4, a murine monoclonal antibody that is specific for acetylated LDL and malondialdehyde-treated LDL, binds specifically to modified LDL present in human atherosclerotic lesions. It is directed against an epitope that is poorly exposed in delipidated and solubilized apolipoprotein B-100 from modified LDL. mAb4E4, as well as its F(ab')2 and Fab fragments, enhanced the uptake of both acetylated LDL and malondialdehyde-treated LDL by THP-1-derived macrophages resulting in a sixfold increase of cytoplasmic cholesteryl ester levels. The increased uptake of modified LDL/mAb4E4 complexes did not occur via the Fc receptor and did not depend on aggregation of modified LDL particles. However, their uptake was inhibited by blocking the scavenger receptors with fucoidin or by downregulation of receptor expression with endotoxins or interferon-gamma, indicating that their uptake is mediated via these receptors. Thus, generation of autoimmune antibodies against modified LDL and subsequent endocytosis of soluble modified LDL/antibody complexes via scavenger receptors may enhance foam cell generation. This mechanism may contribute to the progression of atherosclerotic lesions.

Citing Articles

Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.

Holvoet P, Danloy S, DeRidder E, Lox M, Bernar H, Dhoest A J Clin Invest. 1998; 102(2):379-85.

PMID: 9664079 PMC: 508896. DOI: 10.1172/JCI3038.

Lipoxygenase treatment render low-density lipoprotein susceptible to Cu2+-catalysed oxidation.

Lass A, Belkner J, Esterbauer H, Kuhn H Biochem J. 1996; 314 ( Pt 2):577-85.

PMID: 8670073 PMC: 1217088. DOI: 10.1042/bj3140577.

Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.

Holvoet P, Perez G, Zhao Z, Brouwers E, Bernar H, Collen D J Clin Invest. 1995; 95(6):2611-9.

PMID: 7769103 PMC: 295944. DOI: 10.1172/JCI117963.

References

Cooper J . Effects of cytochalasin and phalloidin on actin. J Cell Biol. 1987; 105(4):1473-8. PMC: 2114638. DOI: 10.1083/jcb.105.4.1473. View

Parham P, Androlewicz M, Brodsky F, Holmes N, Ways J . Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J Immunol Methods. 1982; 53(2):133-73. DOI: 10.1016/0022-1759(82)90137-5. View

Brown M, Goldstein J . Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983; 52:223-61. DOI: 10.1146/annurev.bi.52.070183.001255. View

Goldstein J, Basu S, Brown M . Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983; 98:241-60. DOI: 10.1016/0076-6879(83)98152-1. View

Clevidence B, MORTON R, West G, Dusek D, Hoff H . Cholesterol esterification in macrophages. Stimulation by lipoproteins containing apo B isolated from human aortas. Arteriosclerosis. 1984; 4(3):196-207. DOI: 10.1161/01.atv.4.3.196. View

Marcel Y, Hogue M, Weech P, Milne R . Characterization of antigenic determinants on human solubilized apolipoprotein B. Conformational requirements for lipids. J Biol Chem. 1984; 259(11):6952-7. View

Holvoet P, Lijnen H, Collen D . A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo. J Biol Chem. 1985; 260(22):12106-11. View

Ross R . The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986; 314(8):488-500. DOI: 10.1056/NEJM198602203140806. View

Steinbrecher U . Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem. 1987; 262(8):3603-8. View

10.

MORTON R, West G, Hoff H . A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. J Lipid Res. 1986; 27(11):1124-34. View

11.

Hogg P, Johnston S, Bowles M, Ponds S, Winzor D . Evaluation of equilibrium constants for antigen-antibody interactions by solid-phase immunoassay: the binding of paraquat to its elicited mouse monoclonal antibody. Mol Immunol. 1987; 24(7):797-801. DOI: 10.1016/0161-5890(87)90064-2. View

12.

Palinski W, Rosenfeld M, Yla-Herttuala S, Gurtner G, Socher S, Butler S . Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989; 86(4):1372-6. PMC: 286692. DOI: 10.1073/pnas.86.4.1372. View

13.

Khoo J, Miller E, McLoughlin P, Steinberg D . Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 1988; 8(4):348-58. DOI: 10.1161/01.atv.8.4.348. View

14.

Steinbrecher U, Lougheed M, Kwan W, Dirks M . Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J Biol Chem. 1989; 264(26):15216-23. View

15.

Vercaemst R, Union A, Rosseneu M, de Craene I, De Backer G, Kornitzer M . Quantitation of plasma free cholesterol and cholesteryl esters by high performance liquid chromatography. Study of a normal population. Atherosclerosis. 1989; 78(2-3):245-50. DOI: 10.1016/0021-9150(89)90230-x. View

16.

Yla-Herttuala S, Palinski W, Rosenfeld M, Parthasarathy S, Carew T, Butler S . Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989; 84(4):1086-95. PMC: 329764. DOI: 10.1172/JCI114271. View

17.

Boyd H, Gown A, Wolfbauer G, Chait A . Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol. 1989; 135(5):815-25. PMC: 1880109. View

18.

Via D, Pons L, Dennison D, Fanslow A, Bernini F . Induction of acetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1. J Lipid Res. 1989; 30(10):1515-24. View

19.

Rosenfeld M, Palinski W, Yla-Herttuala S, Butler S, Witztum J . Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 1990; 10(3):336-49. DOI: 10.1161/01.atv.10.3.336. View

20.

Libby P, Hansson G . Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991; 64(1):5-15. View